Akebia Therapeutics Inc. (AKBA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Akebia Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.76
+15.78% today
Market cap
$183M
Overall quality
35/100
Kronos AI 30-day
—
Akebia Therapeutics Inc. (AKBA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $183M. It trades at $0.76, up 15.78% today. Its overall quality score is 35 out of 100, ranked against the whole US market. 5 analysts' average target of $3.90 implies +413.2% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.90 |
| Low – high | $1.00 – $6.00 |
| Analysts | 5 |
| Upside to average | +413.2% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 38 |
| Solvency | 33 |
| Growth | 33 |
| Overall | 35 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.